Biochemicals

Items 31-40 of 54

per page
Set Descending Direction
  1. MOTS-c (human)
    CAS  1627580-64-6
    AG-CP3-0026
    AG-CP3-0026-M0011 mg
    CHF 180.00
    AG-CP3-0026-M0055 mg
    CHF 630.00
    MOTS-c (human)
  2. MOTS-c (K14Q Mutant) (human)
    AG-CP3-0033
    AG-CP3-0033-M0011 mg
    CHF 180.00
    AG-CP3-0033-M0055 mg
    CHF 630.00
    MOTS-c (K14Q Mutant) (human)
  3. Mubritinib
    CAS  366017-09-6
    AG-CR1-3755
    AG-CR1-3755-M0055 mg
    CHF 35.00
    AG-CR1-3755-M02525 mg
    CHF 140.00
    Mubritinib
  4. N-Acetyl-D-glucosamine
    CAS  7512-17-6
    AG-CN2-0489
    AG-CN2-0489-M250250 mg
    CHF 15.00
    AG-CN2-0489-G0011 g
    CHF 25.00
    AG-CN2-0489-G0055 g
    CHF 65.00
    N-Acetyl-D-glucosamine
  5. N1-Guanyl-1,7-diaminoheptane [GC7]
    CAS  150417-90-6 (parent 150333-69-0)
    AG-CR1-3702
    AG-CR1-3702-M01010 mg
    CHF 140.00
    AG-CR1-3702-M05050 mg
    CHF 420.00
    N1-Guanyl-1,7-diaminoheptane [GC7]
  6. Oligomycin A
    CAS  579-13-5
    AG-CN2-0517
    AG-CN2-0517-M0011 mg
    CHF 60.00
    AG-CN2-0517-M0055 mg
    CHF 180.00
    AG-CN2-0517-M01010 mg
    CHF 300.00
    Oligomycin A
  7. Radicicol
    CAS  12772-57-5
    AG-CN2-0021
    AG-CN2-0021-M0011 mg
    CHF 50.00
    AG-CN2-0021-M0055 mg
    CHF 200.00
    Radicicol
  8. Retatrutide . sodium salt
    CAS  2381089-83-2 (free acid)
    AG-CP3-0044
    AG-CP3-0044-M0011 mg
    CHF 125.00
    AG-CP3-0044-M0055 mg
    CHF 375.00
    AG-CP3-0044-M02525 mg
    CHF 1'125.00

    BULK available!
    Research Use Only (RUO). NOT ALLOWED FOR USE IN HUMANS.

    Learn more about GLP-1 & GIP Receptor Agonists

    Retatrutide . sodium salt
  9. Ritonavir
    CAS  155213-67-5
    AG-CR1-3683
    AG-CR1-3683-M01010 mg
    CHF 50.00
    AG-CR1-3683-M05050 mg
    CHF 140.00
    Ritonavir
  10. Rotenone
    CAS  83-79-4
    AG-CN2-0516
    AG-CN2-0516-G0011 g
    CHF 65.00
    AG-CN2-0516-G0055 g
    CHF 150.00
    Rotenone

Items 31-40 of 54

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.